371 related articles for article (PubMed ID: 23175390)
1. The protein arginine deiminases: Structure, function, inhibition, and disease.
Bicker KL; Thompson PR
Biopolymers; 2013 Feb; 99(2):155-63. PubMed ID: 23175390
[TBL] [Abstract][Full Text] [Related]
2. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
3. Chemical biology of protein citrullination by the protein A arginine deiminases.
Mondal S; Thompson PR
Curr Opin Chem Biol; 2021 Aug; 63():19-27. PubMed ID: 33676233
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor.
Aliko A; Kamińska M; Falkowski K; Bielecka E; Benedyk-Machaczka M; Malicki S; Kozieł J; Wong A; Bryzek D; Kantyka T; Mydel P
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052493
[TBL] [Abstract][Full Text] [Related]
5. The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs).
Nemmara VV; Subramanian V; Muth A; Mondal S; Salinger AJ; Maurais AJ; Tilvawala R; Weerapana E; Thompson PR
ACS Chem Biol; 2018 Mar; 13(3):712-722. PubMed ID: 29341591
[TBL] [Abstract][Full Text] [Related]
6. Methods for the detection of peptidylarginine deiminase (PAD) activity and protein citrullination.
Hensen SM; Pruijn GJ
Mol Cell Proteomics; 2014 Feb; 13(2):388-96. PubMed ID: 24298040
[TBL] [Abstract][Full Text] [Related]
7. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.
Wang S; Wang Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1126-35. PubMed ID: 23860259
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of peptidyl-arginine deiminase (PAD): can it control multiple inflammatory disorders as a promising therapeutic strategy?
Padhy DS; Palit P; Ikbal AMA; Das N; Roy DK; Banerjee S
Inflammopharmacology; 2023 Apr; 31(2):731-744. PubMed ID: 36806957
[TBL] [Abstract][Full Text] [Related]
9. Differential, Stage Dependent Detection of Peptidylarginine Deiminases and Protein Deimination in Lewy Body Diseases-Findings from a Pilot Study.
Mercer A; Jaunmuktane Z; Hristova M; Lange S
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361903
[TBL] [Abstract][Full Text] [Related]
10. Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
Knuckley B; Causey CP; Jones JE; Bhatia M; Dreyton CJ; Osborne TC; Takahara H; Thompson PR
Biochemistry; 2010 Jun; 49(23):4852-63. PubMed ID: 20469888
[TBL] [Abstract][Full Text] [Related]
11. Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity.
Slack JL; Jones LE; Bhatia MM; Thompson PR
Biochemistry; 2011 May; 50(19):3997-4010. PubMed ID: 21466234
[TBL] [Abstract][Full Text] [Related]
12. Citrullinated Autoantigens: From Diagnostic Markers to Pathogenetic Mechanisms.
Muller S; Radic M
Clin Rev Allergy Immunol; 2015 Oct; 49(2):232-9. PubMed ID: 25355199
[TBL] [Abstract][Full Text] [Related]
13. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D
Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941
[TBL] [Abstract][Full Text] [Related]
14. Peptidyl Arginine Deiminases in Chronic Diseases: A Focus on Rheumatoid Arthritis and Interstitial Lung Disease.
Nava-Quiroz KJ; López-Flores LA; Pérez-Rubio G; Rojas-Serrano J; Falfán-Valencia R
Cells; 2023 Dec; 12(24):. PubMed ID: 38132149
[TBL] [Abstract][Full Text] [Related]
15. Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.
Witalison EE; Thompson PR; Hofseth LJ
Curr Drug Targets; 2015; 16(7):700-10. PubMed ID: 25642720
[TBL] [Abstract][Full Text] [Related]
16. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.
Jones JE; Causey CP; Knuckley B; Slack-Noyes JL; Thompson PR
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):616-27. PubMed ID: 19736621
[TBL] [Abstract][Full Text] [Related]
17. Peptidyl Arginine Deiminases and Neurodegenerative Diseases.
Tu R; Grover HM; Kotra LP
Curr Med Chem; 2016; 23(2):104-14. PubMed ID: 26577926
[TBL] [Abstract][Full Text] [Related]
18. Halogen Bonding Increases the Potency and Isozyme Selectivity of Protein Arginine Deiminase 1 Inhibitors.
Mondal S; Gong X; Zhang X; Salinger AJ; Zheng L; Sen S; Weerapana E; Zhang X; Thompson PR
Angew Chem Int Ed Engl; 2019 Sep; 58(36):12476-12480. PubMed ID: 31276611
[TBL] [Abstract][Full Text] [Related]
19. Citrullination regulates the expression of insulin-like growth factor-binding protein 1 (IGFBP1) in ovine uterine luminal epithelial cells.
Young CH; Rothfuss HM; Gard PF; Muth A; Thompson PR; Ashley RL; Cherrington BD
Reproduction; 2017 Jan; 153(1):1-10. PubMed ID: 29565015
[TBL] [Abstract][Full Text] [Related]
20. Development of Activity-Based Proteomic Probes for Protein Citrullination.
Nemmara VV; Thompson PR
Curr Top Microbiol Immunol; 2019; 420():233-251. PubMed ID: 30203394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
